Free shipping on all orders over $ 500

ARN-21934 

Cat. No. M29392

All AbMole products are for research use only, cannot be used for human consumption.

ARN-21934  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

ARN-21934 is a potent, highly selective, blood-brain barrier (BBB) penetrant inhibitor for human topoisomerase II α over β. ARN-21934 inhibits DNA relaxation with an IC50 of 2 μM as compared to the anticancer agent Etoposide (IC50=120 μM). ARN-21934 exhibits a favorable in vivo pharmacokinetic profile and is a promising lead compound for anticancer research.

Chemical Information
Molecular Weight 360.46
Formula C21H24N6
CAS Number 2230854-93-8
Form Solid
Solubility (25°C) DMSO 8.33 mg/mL (ultrasonic and warming and heat to 60°C)
Storage Powder -20°C
References

[1] Jose Antonio Ortega, et al. J Med Chem. Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β

Related Topoisomerase Products
XR11576

XR11576 (MLN576) is an orally active inhibitor of topoisomerase I and II.

Silatecan

Silatecan (AR-67; DB 67) is a Camptothecin analogue with improved stability and lipophilicity.

9-Hydroxyellipticine hydrochloride 

9-Hydroxyellipticine hydrochloride is a inhibitor of Topo II and RyR.

Moxifloxacin-d4

Moxifloxacin-d4

F14512

F14512 is a polyamine-containing inhibitor of DNA topoisomerase II with a broad spectrum of antitumor activities.

  Catalog
Abmole Inhibitor Catalog




Keywords: ARN-21934  supplier, Topoisomerase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.